35 employees
Triana Biomedicines is a developer of a molecular glue discovery platform to regulate disease.
2019
$110M
from 5 investors over 5 rounds
TRIANA Biomedicines raised $110M on April 6, 2022
Investors: Logos Global Management, LP, Surveyor Capital, Lightspeed Venture Partners, RA Capital Management, L.P. and Atlas Venture